Post-marketing observational study on the efficacy and safety of Neuroguidewire and Guide Catheter NV2 for the treatment of AVM embolization

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1052230050

Enrollment

Registered

2023-06-24

Start date

2023-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral arteriovenous malformations (brain AVM) brain AVM

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who have undergone endovascular treatment for cerebral arteriovenous malformations using CHIKAI guidewires or FUBUKI guiding catheters during the investigations period. 2.Patients who have given consent for the use of their medical information.

Exclusion criteria

Exclusion criteria: 1.Patients treated with unapproved medical devices.

Design outcomes

Primary

Measure	Time frame
The rate of successful delivery of the micro catheter to the targeted locaton in the neurovasculature (Y/N). Definition of successful delivery; The microcatheter tip should be located in an anatomically desirable location int the vessel to be treated.	—

Countries

Germany, Japan

Contacts

Public ContactMiyahito Kugai

Kotobuki Social Medical Corporation Tominaga Hospital

investigationclinical.001@gmail.com+81-6-6568-1601

Outcome results